CAMBRIDGE, MA, March 30, 2014 (Press-News.org) Paul W. Bohn, Arthur J Schmitt Professor of Chemical & Biomolecular Engineering, University of Notre Dame, to give a presentation titled "Tight Coupling of Chemical Sensing and Reactivity in Nanofluidic Architectures" at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA.
Paul Bohn received his Ph.D. in Chemistry from the University of Wisconsin-Madison. He subsequently joined the faculty at the University of Illinois at Urbana-Champaign, where he served in numerous roles, including Head of the Chemistry Department, Director of the School of Chemical Sciences, and the Interim Vice Chancellor for Research. In 2006, he became the Arthur J. Schmitt Professor of Chemical & Biomolecular Engineering and Professor of Chemistry and Biochemistry at the University of Notre Dame and serves as the Director of the Advanced Diagnostics and Therapeutics Initiative, which fosters research creating tools to combat disease, promote health, and safeguard the environment.
Dr. Bohn has over 225 publications in the fields of analytical chemistry, materials science, and chemical engineering; has served as Editor for the Americas (2007-2009) and Chair of the Editoral Board (2010-2013) for Analyst; and sits on numerous editorial and scientific boards. In addition to being a Fellow of the American Association for the Advancement of Science (1998) and the Royal Society of Chemistry (UK, 2008), he has received several awards including the ACS Award in Spectrochemical Analysis (1997), the Bomem-Michelson Award from the Coblentz Society (2005), and the Theophilus Redwood Award of the Royal Society of Chemistry (2010). His research interests include integrated microfluidic and nanofluidic chemical measurement strategies for personal monitoring, chemical and biochemical sensing in mass-limited samples, and molecular approaches to nanotechnology.
For more information, please visit http://www.gtcbio.com/biosensors/agenda
GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.
GTC (Global Technology Community), LLC, is a privately held company founded in 2002.
Jaebum Choo of Hanyang Univ. to speak at Bioanalytical Sensors Mtg, May 22-23, 2014, Cambridge, MA.
Jaebum Choo, professor in the Department of Bionano Technology at the Hanyang University, to give a presentation at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA.
2014-03-30
ELSE PRESS RELEASES FROM THIS DATE:
MagicKitchen.com Expands Local Partner Program to North and South Carolina
2014-03-30
Today, Greg Miller, CEO of MagicKitchen.com announced a new partner in the MagicKitchen.com Local Partner Program for North and South Carolina. "Our new Partner Hearthside Home Care in Greensboro, North Carolina will represent our full line of HomeStyle and Special Diets menu items to the full spectrum of residential and commercial prepared meal customers in both North and South Carolina." said Greg Miller.
MagicKitchen.com customers include Healthcare Organizations and Health Plans, specialized medical facilities such as clinics, dialysis centers, assisted living facilities, ...
Thousand Oaks Surgeon Offers Non-Surgical Facelift With JUVEDERM VOLUMA XC
2014-03-30
Renowned plastic surgeon Dr. Kouros Azar (www.azarplasticsurgery.com) is the leading injector of JUVEDERM VOLUMA XC in Thousand Oaks, where his plastic surgery practice offers the new dermal filler as an anti-aging option that doesn't require surgery.
Dr. Azar was one of only 2 plastic surgeons in Southern California to receive VOLUMA XC before anyone else after it was approved by the FDA in fall 2013, and he is now one of a handful of surgeons in the region who trains other doctors in the use of the product. More patients get VOLUMA XC injections at the plastic surgeon's ...
Risk Management Executive, James Hice, Named Risk Manager and General Counsel at McCusker & Company
2014-03-30
Risk Management executive, and highly-regarded industry insider, James Hice, was today named Risk Manager and General Counsel at McCusker & Company, a leading international provider of warranty protection solutions for the commercial and consumer electronics industry.
"I am pleased to name James Hice our new Risk Manager and General Counsel," said McCusker & Company Chief Executive Officer Will L. McCusker. "His connections, insight, expertise and industry knowledge will be invaluable for our company."
Hice was the Vice President of Operations and Procurement ...
Envision Built Offers Custom Built Transformations of Screened Porches and Patios into Spacious Three Season Sunrooms to Extend Living Spaces in Cary, Durham and the Greater Raleigh NC Area
2014-03-30
Envision Built Home Remodeling is a custom home renovation specialist - transform your screened porch or patio into a three seasons sunroom, extending the living space of your home. Envision Built is an award-winning remodeling designer and builder.
"A fairly easy way to extend the living space in your home is convert your screened porch or patio into a beautiful sunroom," said Bill Ahle, Owner of Envision Built. "Every major renovation begins with a five hour design session working with our interior designer to help you develop a plan, select color schemes and to map ...
SchureMed to Unveil Schure Loc XPS Medical Device at AORN in Chicago
2014-03-30
SchureMed announced today plans to present their newest and most innovative surgical positioning device at the AORN Show at McCormick Place in Chicago IL. The Schure Loc XPS Extremity Positioning System advances surgical patient positioning by combining both absolute rigid fixation of the patient's limb with unlimited range of motion both pre- and intra-operatively during shoulder arthroscopy, rotator cuff and total shoulder replacement procedures.
Unlike other devices that use bulky hydraulic systems and supplementary power units, the Schure Loc XPS employs an ingenious ...
Texas Based Modern Intellects Artist Gift Releases The Trip EP
2014-03-29
The release of Gift's EP "The Trip" has been eagerly awaited by fans since mid-2013, the uniquely creative video countdown gave fans but a glimpse inside the mind of the independent rapper and the creative process of the project, leaving listeners and viewers wanting more.
Gift first began writing at 16 years old after a serious hamstring injury that ended his future in track and field, but ended up being what would pave the way for his future. Fans have the choice of downloading the EP for free or making a donation by visiting www.giftrapsmusic.com or the artist's SoundCloud ...
Relaxed blood pressure guidelines cut millions from needing medication
2014-03-29
DURHAM, N.C. – New guidelines that ease the recommended blood pressure could result in 5.8 million U.S. adults no longer needing hypertension medication, according to an analysis by Duke Medicine researchers.
The findings are the first peer-reviewed analysis to quantify the impact of guidelines announced in February by the Eighth Joint National Committee. In a divisive move, the committee relaxed the blood pressure goal in adults 60 years and older to 150/90, instead of the previous goal of 140/90.
Blood pressure goals were also eased for adults with diabetes and kidney ...
Study estimates proportion of adults affected by new blood pressure guideline
2014-03-29
Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.
Ann Marie Navar-Boggan, M.D., Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues quantified the proportion of adults potentially ...
US, European cholesterol guidelines differ in statin use recommendations
2014-03-29
Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.
The common approach in cardiovascular disease (CVD) primary prevention is to identify individuals at high enough risk to justify more intensive lifestyle ...
Analysis supports use of risk equations to guide statin therapy
2014-03-29
In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published ...
LAST 30 PRESS RELEASES:
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
[Press-News.org] Jaebum Choo of Hanyang Univ. to speak at Bioanalytical Sensors Mtg, May 22-23, 2014, Cambridge, MA.Jaebum Choo, professor in the Department of Bionano Technology at the Hanyang University, to give a presentation at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA.